What is AnaptysBio, Inc.'s net investment in lease?

AnaptysBio, Inc. (ANAB) reported net investment in lease of $12.04M in Q1 2026.

How has AnaptysBio, Inc.'s net investment in lease changed year-over-year?

AnaptysBio, Inc.'s net investment in lease decreased by 13.5% year-over-year, from $13.92M to $12.04M.

What is the long-term trend for AnaptysBio, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), AnaptysBio, Inc.'s net investment in lease has grown at a 105.2% compound annual growth rate (CAGR), from $344K to $12.52M.

AnaptysBio, Inc. ANAB Net Investment in Lease

Net Investment in Lease at other companies

BiogenBIIB

——

Dianthus TherapeuticsDNTH

——

AbCellera Biologics Inc.ABCL

——

Apogee Therapeutics, Inc.APGE

——

BridgeBio PharmaBBIO

——

PrecigenPGEN

——

Other financials

Income statement

See full

Revenue$25.6M-8.0%

Operating income-$34.6M-25.8%

Net income-$52.9M-34.5%

EPS (diluted)-$1.84-43.8%

Balance sheet

See full

Cash & equivalents$248.5M+152%

Total debt$13.6K-99.9%

Total equity$12.7M-62.5%

Total assets$329.7M-21.9%

Cash flow

See full

Operating cash flow-$25.9M-142%

CapEx$17.0K-51.4%

Free cash flow-$25.9M-142%

Valuation

See full

Market cap$1.73B+180%

Enterprise value$1.48B+176%

P/S7.4×+1.9×

Profitability

See full

Operating margin17.6%+9.6pp

Net margin-49.9%-22.6pp

FCF margin1.9%+1.0pp

Returns & leverage

See full

Return on equity-343.8%-1,012pp

Debt / equity0×-0.5×

Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AnaptysBio, Inc.'s net investment in lease?: AnaptysBio, Inc. (ANAB) reported net investment in lease of $12.04M in Q1 2026.
How has AnaptysBio, Inc.'s net investment in lease changed year-over-year?: AnaptysBio, Inc.'s net investment in lease decreased by 13.5% year-over-year, from $13.92M to $12.04M.
What is the long-term trend for AnaptysBio, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), AnaptysBio, Inc.'s net investment in lease has grown at a 105.2% compound annual growth rate (CAGR), from $344K to $12.52M.